6 Mistakes Digital Health Startups Make When Seeking Funding or Customers
At ViVE, investors and health system executives shared their biggest pet peeves when it comes to pitches from digital health startups.
Growth or Profitability: Which One Do Investors Care More About?
In the venture capital community, there’s a bit of a debate about what matters more to digital health investors in today's fundraising environment — growth or profitability. Cathy Gao, a partner at Sapphire Ventures, thinks VCs are still putting a premium on growth, but she noted that the conversation is very nuanced.
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
In competitive market for MSK, Sword valued at $2B
Sword Health, one of several companies looking to take a digital approach to musculoskeletal care, recently closed an oversubscribed $163 million series D round, giving it a $2 billion valuation.
Investors pour $91M into growing clinical-trial software firm
The Covid-19 pandemic is altering behavior and fueling demand for remote technologies in clinical trials with Medable, a company in the clinical trial software space, looking to capitalize.